Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer

Cell Reports
Young-Eun ChoiDipanjan Chowdhury

Abstract

High-grade serous ovarian carcinomas (HGSOCs) with BRCA1/2 mutations exhibit improved outcome and sensitivity to double-strand DNA break (DSB)-inducing agents (i.e., platinum and poly(ADP-ribose) polymerase inhibitors [PARPis]) due to an underlying defect in homologous recombination (HR). However, resistance to platinum and PARPis represents a significant barrier to the long-term survival of these patients. Although BRCA1/2-reversion mutations are a clinically validated resistance mechanism, they account for less than half of platinum-resistant BRCA1/2-mutated HGSOCs. We uncover a resistance mechanism by which a microRNA, miR-622, induces resistance to PARPis and platinum in BRCA1 mutant HGSOCs by targeting the Ku complex and restoring HR-mediated DSB repair. Physiologically, miR-622 inversely correlates with Ku expression during the cell cycle, suppressing non-homologous end-joining and facilitating HR-mediated DSB repair in S phase. Importantly, high expression of miR-622 in BRCA1-deficient HGSOCs is associated with worse outcome after platinum chemotherapy, indicating microRNA-mediated resistance through HR rescue.

References

Sep 25, 2007·Methods : a Companion to Methods in Enzymology·Ulf Andersson Orom, Anders H Lund
Feb 13, 2008·Cell·Asako Sakaue-SawanoAtsushi Miyawaki
Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
Feb 16, 2010·Nature Structural & Molecular Biology·Dong-Hyun LeeDipanjan Chowdhury
May 11, 2010·Nature Structural & Molecular Biology·Peter BouwmanJos Jonkers
Oct 23, 2010·Molecular Cell·Alberto Ciccia, Stephen J Elledge
Mar 1, 2011·Gynecologic Oncology·Karin K ShihDouglas A Levine
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara NorquistElizabeth M Swisher
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 31, 2011·Molecular and Cellular Biology·Steven S FosterJohn H J Petrini
Mar 27, 2012·Molecular Cell·Samuel F BuntingAndré Nussenzweig
May 4, 2012·Journal of Cell Science·J Ross ChapmanStephen P Jackson
Aug 28, 2012·Molecular Cell·J Ross ChapmanSimon J Boulton
Jun 19, 2013·Cell Reports·Alessia BalestriniJohn H J Petrini
Sep 21, 2013·Annual Review of Genetics·Ludovic Deriano, David B Roth
Oct 22, 2013·Genes & Development·Stoil D DimitrovDavid M Livingston
May 23, 2015·Journal of the National Cancer Institute·Guoyan LiuWei Zhang
Oct 16, 2015·Cancer Discovery·Panagiotis A KonstantinopoulosAlan D D'Andrea

❮ Previous
Next ❯

Citations

May 19, 2017·Journal of the National Cancer Institute·Jac A NickoloffRobert Hromas
Jun 24, 2017·Expert Opinion on Biological Therapy·Victoria MandilarasStephanie Lheureux
Jun 20, 2017·Journal of Cellular Physiology·Aynaz MihanfarHamid Reza Nejabati
Mar 1, 2018·Endocrine-related Cancer·Belinda van ZylNikola A Bowden
Oct 24, 2018·International Journal of Molecular Sciences·Margarita RomeoRicard Mesía
Jul 4, 2020·Essays in Biochemistry·Ruth F Ketley, Monika Gullerova
Dec 21, 2017·Expert Review of Anticancer Therapy·Roberto FerraraDavide Melisi
Mar 22, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sarah A Cook, Anna V Tinker
Nov 17, 2019·International Journal of Molecular Sciences·Josep Marí-AlexandreJuan Gilabert-Estellés
Oct 6, 2020·Frontiers in Cell and Developmental Biology·Maddison RoseEmma Bolderson
Oct 31, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roopa Thapar
Sep 9, 2018·Molecular Biology Reports·Rongrong LiaoLihui Zhu
Feb 2, 2020·Journal of Hematology & Oncology·Chenggong SunBeihua Kong
Aug 5, 2020·Cancer Science·Kosuke YoshidaYusuke Yamamoto
Aug 25, 2019·International Journal of Molecular Sciences·Jin-Hong Kim
Jan 4, 2020·Journal of Experimental & Clinical Cancer Research : CR·Enrica VescarelliSimona Ceccarelli
Jan 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhong-Yi DongYi-Long Wu
Jan 26, 2021·Experimental & Molecular Medicine·Dae-Seok KimW Lee Kraus
Feb 9, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M ChiappaG Damia
Mar 22, 2020·Pharmacology & Therapeutics·Hunter D Reavis, Ronny Drapkin
Aug 10, 2019·Mutation Research. Reviews in Mutation Research·Wei-Hsien HouXiaochun Yu
Jun 12, 2019·Biochemical Pharmacology·Alice RaineriMarta Menegazzi
Apr 24, 2021·Medical Oncology·Devashish DesaiRashmika Potdar
Apr 19, 2021·Cancer Cell International·Yufei TangFenggang Hou
Apr 20, 2021·Frontiers in Immunology·Xueqin ZouQixiang Shao
May 1, 2021·Biomolecules·Matvey Mikhailovich MurashkoDenis Eriksonovich Demin
Jan 12, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Delphine L Chen
Jul 22, 2021·Nature Reviews. Clinical Oncology·Mariana Paes DiasJos Jonkers
Aug 8, 2021·International Journal of Molecular Sciences·Michela PalleschiUgo De Giorgi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

BJOG : an International Journal of Obstetrics and Gynaecology
Asima MukhopadhyayRichard J Edmondson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Barbara M NorquistElizabeth M Swisher
International Journal of Radiation Oncology, Biology, Physics
Charlene Kan, Junran Zhang
© 2022 Meta ULC. All rights reserved